The risk of serious infection in rheumatoid arthritis patients receiving tocilizumab compared with tumor necrosis factor inhibitors in Korea

Authors:

Abstract
No abstract available
Funding Information
  • Ministry of Food and Drug Safety (19172MFDS170)

This publication has 31 references indexed in Scilit: